Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 19

Cross-Polarized Macro Photography versus Polarized Dermoscopy in Basal Cell Carcinoma: A Blinded Paired-Image Comparison

Authors Erdem O, Erdemir VA, Dağtaş BB, Koku Aksu AE ORCID logo, Ertekin SS, Yilmaz A, Gökyayla E, Gençoğlan G, Göktay F, Gürel MS

Received 28 February 2026

Accepted for publication 14 April 2026

Published 23 April 2026 Volume 2026:19 605974

DOI https://doi.org/10.2147/CCID.S605974

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Anne-Claire Fougerousse



Ozan Erdem,1 Vefa Aslı Erdemir,1 Buğra Burç Dağtaş,1 Ayşe Esra Koku Aksu,2 Sümeyre Seda Ertekin,3 Abdurrahim Yilmaz,4 Ece Gökyayla,5 Gülsüm Gençoğlan,6 Fatih Göktay,7 Mehmet Salih Gürel1

1Department of Dermatology and Venereology, Istanbul Medeniyet University, Istanbul, Turkey; 2Department of Dermatology and Venereology, Istanbul Teaching and Research Hospital, Health Sciences University, Istanbul, Turkey; 3Department of Dermatology and Venereology, Memorial Goztepe Hospital, Memorial Health Group, Istanbul, Turkey; 4Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; 5Department of Dermatology and Venereology, Ege University, Izmir, Turkey; 6Dermatology and Venereology, Medicana Atakoy Hospital, Medicana Health Group, Istanbul, Turkey; 7Dermatology and Venereology, Private Dermatology Clinic, Istanbul, Turkey

Correspondence: Ozan Erdem, Istanbul Medeniyet University, Department of Dermatology and Venereology, Istanbul, Turkey, Email [email protected]

Background: Polarized dermoscopy (PD) is the established non-contact imaging modality for basal cell carcinoma (BCC). Cross-polarized macro photography (CPMP) applies analogous optical principles using widely available equipment, but its performance relative to PD has not been systematically evaluated.
Objective: To compare dermoscopic feature visibility, image quality, and expert modality preference between CPMP and PD in BCC using a blinded, paired-image design.
Methods: One hundred paired CPMP and PD images of histopathologically confirmed BCCs, acquired during the same clinical visit, were digitally masked to remove modality-revealing cues and reviewed in randomized side-by-side pairs. Feature visibility was assessed by three dermoscopists; image quality by a multidisciplinary panel using the DIQS-5 (a structured 5-point dermoscopic image quality scale); and modality preference by three dermatologists with varying CPMP familiarity across two blinded rounds with a washout period.
Results: Feature visibility did not differ significantly for any established BCC criterion (all P > 0.05). CPMP scored significantly higher for depth of field and color fidelity (both P < 0.001); sharpness was comparable between modalities (P = 0.494). CPMP captured all lesions ≥ 1 cm in a single frame, whereas 41.5% of large lesions exceeded PD’s field of view. The majority of raters preferred CPMP in both evaluation rounds, with phenotype-dependent patterns: CPMP was favored for pigment-rich lesions and PD for lesions with fine vascular structures.
Conclusion: CPMP demonstrated feature visibility comparable to PD while offering measurable advantages in depth of field, field of view, and color rendering, suggesting complementary roles for these modalities in BCC imaging.

Plain Language Summary: Basal cell carcinoma is the most common skin cancer. Dermatologists usually examine these lesions with a handheld device called a dermoscope, which uses a special polarized light to reveal details beneath the skin surface. Standard dermoscopes work best when held close to the skin and cover a small area at a time, which can be challenging with larger growths. We wanted to know whether a photographic technique called cross-polarized macro photography (which uses the same type of light but works at a distance with a regular camera) could show the same information.
We studied 100 people diagnosed with basal cell carcinoma. For each person, we had two images of the same skin area: one taken with the camera technique and one with a dermoscope. Different skin specialists reviewed the paired images side by side, without knowing which technique produced each image. They recorded what they could see, scored the image quality, and chose which image they found more useful.
We found that both techniques showed the important visual features of basal cell carcinoma equally well. The camera technique produced sharper focus across the whole lesion, more accurate colors, and a wider view, often capturing larger growths in a single image. Dermoscopy showed fine blood vessels slightly more clearly.
These results suggest that cross-polarized macro photography can work alongside dermoscopy in everyday practice. Each technique has its own strengths, and together they may give clinicians a more complete picture when examining skin lesions. Left side shows two labelled device setups. Upper left setup labels: DSLR Camera above a Macro lens; below the lens a Ring flash and CP filter; below, a labelled Basal cell carcinoma cross section. Legend labels: Polarized light, Depolarized light, Blocked light. Lower left setup labels: Polarized dermoscope above a labelled Basal cell carcinoma cross section, with the same legend labels. Center shows two large labelled arrows: “ 100 paired images of BCC lesions” followed by “Anonymized, randomized, blinded evaluation.” Right side shows four clinical photographs arranged as two at the top and two at the bottom. Right text lists labels under CPMP: Better depth of field; Better color fidelity; Wider field of view. Right text lists labels under PD: Finer vascular detail; Similar visibility of key BCC features.Labelled diagram comparing Cross-polarized Macro Photography and Non-contact Polarized Dermoscopy for Basal cell carcinoma.

Keywords: dermoscopic feature visibility, image quality, medical photography, non-contact imaging, skin cancer imaging, optical imaging

Introduction

Basal cell carcinoma (BCC) is the most common skin cancer worldwide, and its rising incidence imposes a substantial burden on patients and healthcare systems.1 Although BCC typically follows an indolent course with low metastatic potential, delayed diagnosis or untreated lesions may result in extensive local tissue destruction, functional impairment, and considerable cosmetic morbidity.2 Therefore, timely and accurate diagnosis is critical not only for improving patient outcomes but also for reducing the need for complex surgical interventions and related resource use.3,4 While clinical examination remains the cornerstone of diagnosis, non-invasive imaging modalities are playing an increasingly central role in detection, treatment planning, and longitudinal monitoring of BCC.5–8

Among these modalities, approaches based on cross-polarization occupy a pivotal position. Since its introduction to dermatology by Anderson in 1991,9 cross-polarization has become a core optical principle in skin imaging. In contrast to non-polarized imaging, in which surface-reflected light hinders visualization of deeper structures, cross-polarization suppresses this glare through the use of two orthogonally oriented polarizing filters, thereby enhancing the visibility of deeper subsurface features, including vascular and collagen-related structures that are imperceptible to the naked eye.10 In addition, by eliminating the need for immersion fluids and direct skin contact required in conventional non-polarized dermoscopy, this technique has evolved into a standard component of contemporary dermoscopes.11,12 At the other end of the spectrum, cross-polarized illumination also underpins high-end platforms such as automated total-body mapping and multimodal facial imaging systems, developed for standardized, reproducible documentation in screening and follow-up.13–15 However, these systems are often limited by high acquisition and maintenance costs, workflow complexity, and restricted availability.

This highlights a practical gap between readily available polarized dermoscopy (PD) and technologically sophisticated platforms that offer non-contact, cross-polarized imaging but are less widely deployable for routine use. In this setting, cross-polarized macro photography (CPMP) may provide a pragmatic bridge. CPMP can be assembled from equipment commonly available in dermatology clinics (a digital camera, macro lens, and ring flash fitted with a cross-polarizing filter) and applies optical principles analogous to PD while enabling non-contact cross-polarized imaging.16,17 However, whether CPMP yields comparable information to standard PD has not been systematically evaluated. Therefore, focusing on BCC, we compared CPMP and PD by assessing dermoscopic feature visibility, image quality parameters, and expert preferences using paired images of the same lesions.

Materials and Methods

Study Design and Ethics

This study was designed as a retrospective, observational, comparative imaging analysis. The study protocol adhered to the principles of the Declaration of Helsinki, and ethical approval was obtained from the institutional ethics committee prior to initiation (approval #: 2025/06-21).

Patient Selection and Dataset Creation

We retrospectively reviewed the digital image archives for images acquired between January 2023 and January 2025. The study cohort consisted of patients with histopathologically confirmed BCC for whom paired CPMP and PD images were available from the same preoperative visit. To minimize operator-dependent variability and ensure high image quality, inclusion was initially restricted to cases where at least three consecutively acquired images were available for each modality. From this pool, a single CPMP and a single PD image that best represented the lesion were selected by consensus between two authors (O.E., V.A.E). The final dataset comprised 100 image pairs, with each pair consisting of one CPMP and one PD image of the same lesion.

Image Acquisition

CPMP images were captured utilizing a Nikon D3500 DSLR camera equipped with a Nikon AF-S 60 mm f/2.8G ED Micro lens and a GODOX ML150 ring flash, combined with a custom-built cross-polarization filter as previously described.16,17 Camera settings were standardized in manual mode to 1/200 s exposure time, f/20 aperture, and ISO 100 sensitivity. All photographs were obtained perpendicular to the lesion at a working distance of approximately 10 ± 2 cm, with image acquisition requiring only a few seconds once the setup was established.

PD images were acquired using either a DermLite DL4 or DL5 dermoscope (3Gen, CA, USA) attached to an iPhone 13 (Apple Inc., CA, USA) via an adapter. Mobile phone camera settings remained in automatic mode to reflect routine clinical practice, while the dermoscope was operated in non-contact cross-polarized mode. All images were captured by a single experienced dermatologist (O.E.) trained in clinical photography and dermoscopic imaging to ensure consistency.

Image Preparation and Randomization

To ensure blinding and eliminate visual cues that might disclose the imaging modality, all images underwent digital pre-processing prior to evaluation. Device-specific elements, such as dermoscope rulers, vignette borders, or other modality revealing clues, were removed using cropping and object removal tools in Adobe Lightroom (version 8.3.1; Adobe Inc., CA, USA). Images were rotated as needed to facilitate side-by-side comparison and accurate anatomical matching of structures (Figure 1). Digital post-processing was strictly limited to cropping; original resolution, brightness, contrast, and sharpness were preserved to maintain data integrity.

A four-panel composite of the same basal cell carcinoma lesion, showing a central white-red structureless area with peripheral pigmented structures. Panel A is a rectangular close-up view, whereas panels B–D are circular close-up views of the same lesion on a black background.

Figure 1 Image pre-processing workflow for modality-blinded evaluation. (A and B) Original cross-polarized macro photography (CPMP) and polarized dermoscopy (PD) images of the same lesion, respectively. Note the rectangular format of the raw CPMP image, and the visible millimeter scale and vignette effect in the raw PD image. (C) Processed CPMP image: A circular crop (mask) was applied to simulate the typical field of view of a dermoscope, rendering the image format indistinguishable from the PD counterpart. (D) Processed PD image: The scale bar was digitally removed, and the image was rotated to achieve anatomical alignment with the CPMP image. A standardized black background was applied to the corners of both processed images to ensure visual consistency.

For each lesion, the CPMP and PD images were arranged in paired side-by-side montages. The presentation order of the lesions and the relative positioning (left vs right) of the modalities within each pair were randomized using a computer-generated sequence. To assess intra-rater consistency, the entire assessment process, including the randomized lesion order and modality positioning, was repeated after a minimum washout period of eight weeks to minimize recall bias.

Image Assessment Parameters

Clinical and Dermoscopic Features

For each lesion, anatomical location, lesion size, overall morphology (flat/slightly elevated, markedly elevated, or depressed) and skin surface contour (flat, convex, or concave) were documented. The presence of visual artifacts, including hair, hemorrhage, purulence/crusting, or suture material, was also noted.

Dermoscopic features characteristic of BCC, as defined in established literature,18 were assessed for each image pair. The presence or absence of the following structures was recorded separately for CPMP and PD images: shiny white-red structureless areas, arborising vessels, ulceration/erosions, maple leaf-like structures, concentric structures, spoke-wheel areas, blue-grey ovoid nests, blue-grey globules/dots, short fine telangiectasia, and white streaks (chrysalis lines).

Image Quality

Image quality was evaluated using a 5-point dermoscopic image quality scale (DIQS-5) specifically developed for this study to enable structured and standardized assessment. The scale comprises three domains:

  1. Focus and depth of field: The extent to which the lesion is well-focused throughout, without relevant blurred or out-of-focus areas.
  2. Sharpness and clarity: The visibility and definition of fine structures such as small vessels or pigmented elements.
  3. Color fidelity: The perceived accuracy of color tones, saturation and contrast for dermoscopic interpretation.

Each domain was rated on a 5-point Likert scale, with higher scores indicating higher perceived image quality. An overall image quality score was calculated as the mean of the three domain scores. Descriptive criteria and representative examples for each DIQS-5 level are provided in Supplementary Figure 1 and Supplementary Table S1.

Modality Preference

Evaluators viewed paired CPMP and PD images side-by-side for each lesion and selected the modality they deemed superior for diagnostic assessment. This selection was based on their overall impression of diagnostic utility, reflecting a composite assessment of feature visibility, image quality, and perceived ease of interpretation.

Rater Characteristics and Blinding

To reduce potential bias, assessments were stratified across specific expert groups. Lesion characteristics were extracted by the corresponding author (O.E). Dermoscopic feature annotation was performed by consensus among three experienced dermatologists (V.A.E., A.E.K.A., S.S.E). Image quality ratings were performed in consensus by a multidisciplinary team comprising two dermatologists (B.B.D., G.G.) and one software engineer specializing in image processing and dermoscopic datasets (A.Y)., to incorporate both clinical and technical perspectives. Subjective preferences were recorded by three independent dermatologists with varying levels of familiarity with the technique: two were familiar with CPMP imaging (M.S.G., F.G.) and one had no prior exposure (EG).

To evaluate intra-rater consistency, the preference assessment was repeated after a minimum washout period of eight weeks using a fully re-randomized image set. All evaluators remained blinded to the imaging modality and patient clinical data throughout the process.

Statistical Analysis

Statistical analyses were performed utilizing R software (version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria). Continuous variables were summarized as mean ± standard deviation (SD) or median with interquartile range (IQR), depending on the normality of distribution (assessed via Shapiro–Wilk test). Categorical variables were presented as frequencies and percentages. The visibility of dermoscopic features between paired CPMP and PD images was compared using McNemar’s test for matched pairs. Differences in DIQS-5 domain scores and overall image quality scores were analyzed using the Wilcoxon signed-rank test. To evaluate the consistency of subjective modality preferences across the three evaluators, the Chi-squared test was employed. Inter-rater reliability for feature annotation was assessed using Fleiss’ kappa, while intra-rater consistency was determined using Cohen’s kappa coefficient. A two-tailed P-value < 0.05 was considered statistically significant.

Results

Lesion Characteristics

Among the 100 evaluated BCCs, most were located on the face (39%), followed by the trunk and extremities (23%), scalp (14%), nose (12%), ear (5%), periorbital region (5%) and perioral area (2%). Lesion sizes were nearly evenly distributed, with 47% measuring < 1 cm and 53% ≥ 1 cm. The majority were flat or slightly elevated (69%), while 27% were markedly elevated and 4% were depressed. The skin surface contour was predominantly flat (73%), followed by convex (20%) and concave (7%).

Visibility of Dermoscopic Features

The comparative visibility of dermoscopic features between CPMP and PD modalities is summarized in Table 1. Key diagnostic features of BCC, including shiny white-red structureless areas, arborising vessels, ulceration or multiple small erosions, maple leaf-like structures, concentric structures, and spoke-wheel areas, were observed with identical frequencies in both CPMP and PD images (matched pairs; P = 1.00 for all). Minor discrepancies were noted for features such as short fine telangiectasia, white streaks (chrysalis lines), and blue-grey globules/dots; however, none of these differences reached statistical significance on McNemar’s test (all P > 0.05).

Table 1 Comparative Visibility of Dermoscopic Features Between Cross-Polarized Macro Photography (CPMP) and Polarized Dermoscopy (PD) in Basal Cell Carcinoma (n = 100)

Image Quality Analysis

Descriptive statistics for each image quality domain (DIQS-5) and overall quality scores are presented in Table 2. CPMP images achieved significantly higher scores for focus and depth of field and color fidelity compared to PD images (P < 0.001 for both). Although sharpness and clarity scores were slightly higher in PD images, this difference did not reach statistical significance (P = 0.494). Consequently, the overall mean image quality scores were significantly higher for CPMP than for PD (P < 0.001).

Table 2 Comparison of Image Quality Scores Between Cross-Polarized Macro Photography (CPMP) and Polarized Dermoscopy (PD) (n = 100)

Field-of-View Analysis

To evaluate the effective field of view, all 100 lesions were assessed to determine whether the entire tumor and its immediate surroundings could be fully captured within a single image frame. Among the 47 lesions measuring < 1 cm, 100% were completely visualized in both CPMP and PD images. In contrast, among the 53 lesions measuring ≥ 1 cm, only 31 (58.5%) could be fully contained within a single PD frame. However, the remaining 22 (41.5%) larger lesions, which exceeded the field of view of standard dermoscopy, were completely captured in a single frame using CPMP (Figure 2).

A two-panel composite of the same basal cell carcinoma lesion, showing shiny white-red structureless areas with multiple small erosions and pigmented structures. The upper panel is a rectangular close-up view of the full lesion, and the lower panel is a circular dermoscopic view with a visible millimeter scale.

Figure 2 Representative comparison of field of view and depth of field between modalities. (A) Cross-polarized macro photography (CPMP) image capturing the entire anatomical extent of a large basal cell carcinoma within a single frame, maintaining uniform sharpness from center to periphery. (B) Polarized dermoscopy (PD) image of the same lesion; note the restricted field of view which fails to encompass the entire tumor, and the peripheral defocus (blurring) caused by the shallow depth of field inherent to standard dermoscopic optics.

Modality Preference and Rater Consistency

In the first evaluation round, all three evaluators demonstrated a preference for CPMP, selecting it as the preferred modality in 51%, 61%, and 60% of cases (EV-1, EV-2, and EV-3, respectively; Figure 3). In the second round (after the washout period), EV-1 shifted preference towards PD (56%), whereas EV-2 and EV-3 continued to favor CPMP (59% and 57%, respectively). No statistically significant differences in preference distribution among evaluators were observed in either round (P = 0.289 and P = 0.070, respectively).

Two heatmaps of evaluator preferences by evaluator and method, with cell percentages for each combination.

Figure 3 Heatmap illustrating subjective evaluator preferences for cross-polarized macro photography (CPMP) and polarized dermoscopy (PD) images across two evaluation rounds. Values indicate the percentage of cases in which each evaluator (EV-1 to EV-3) favored a specific modality. Left panel represents the initial assessment (Round 1), and the right panel shows preferences after the washout period (Round 2). No statistically significant differences in preference distributions were observed among evaluators in either round (P = 0.289 and P = 0.070, respectively; Chi-squared test).

Inter-rater reliability was fair and statistically significant in both the first (κ = 0.35, P < 0.001) and second (κ = 0.28, P < 0.001) rounds. Intra-rater consistency was highest for evaluator EV-3 (κ = 0.53; 95% CI: 0.36–0.70), while EV-2 (κ = 0.29; 95% CI: 0.10–0.48) and EV-1 (κ = 0.26; 95% CI: 0.08–0.45) showed lower levels of consistency.

Analysis of High-Consensus Cases

To identify factors influencing modality preference, we analyzed a subset of lesions with high inter-rater consistency, defined as cases where at least five of the six assessments favored the same modality (n = 59). Complete agreement (6/6) was observed in 24 cases (41%), and near-complete agreement (5/6) in 35 cases (59%).

Within this high-consensus subset, CPMP images were preferred in 37 cases (63%) and PD images in 22 cases (37%). Image quality differences in this subset mirrored the overall cohort: CPMP images scored significantly higher for focus and depth of field (P = 0.029) and color fidelity (P < 0.001), with no significant difference in sharpness and clarity (P = 0.657).

Specific dermoscopic features significantly influenced modality preference. Short fine telangiectasia were detected in 38 of the 59 cases and were significantly associated with a preference for PD (18/22 PD-preferred cases; P = 0.031). Conversely, blue-grey ovoid nests (present in 24 cases) were more commonly observed in CPMP-preferred lesions (20/37; P = 0.007). Similarly, maple leaf-like structures (present in 18 cases) were predominantly found in CPMP-preferred lesions (15/18; P = 0.030). Other clinical variables, including anatomical location, lesion size, morphology, surface contour, and the presence of artifacts, did not significantly influence modality selection (all P > 0.05). Representative high-consensus cases are illustrated in Figures 4 and 5.

A 2×2 composite of four paired images comparing cross-polarized macro photography (left in each pair) with polarized dermoscopy (right) of four basal cell carcinoma lesions.

Figure 4 Representative high-consensus cases in which evaluators consistently favored cross-polarized macro photography (CPMP) (agreement ≥5/6). Within each image pair, the CPMP image is shown on the left and the polarized dermoscopy (PD) image on the right for direct visual comparison (note: image presentation was randomized during the blinded evaluation). Panels (AD) show four representative lesions from this subgroup. These cases include predominantly pigmented and/or crusted lesions, as well as lesions with convex or elevated morphology, in which the greater depth of field and color fidelity of CPMP appeared advantageous for overall lesion assessment.

A 2×2 composite of four paired images comparing cross-polarized macro photography (left in each pair) with polarized dermoscopy (right) of four basal cell carcinoma lesions.

Figure 5 Representative high-consensus cases in which evaluators consistently favored polarized dermoscopy (PD) (agreement ≥5/6). Within each image pair, the CPMP image is shown on the left and the PD image on the right for direct visual comparison (note: image presentation was randomized during the blinded evaluation). Panels (AD) show four representative lesions from this subgroup. These cases were predominantly non-pigmented or hypopigmented and were characterized by fine vascular structures and/or relatively flat surface contours, in which the sharper depiction of delicate vascular detail by PD appeared advantageous.

Discussion

In this study, CPMP provided diagnostic information and overall image quality broadly comparable to non-contact PD for the evaluation of BCC. Across the predefined dermoscopic criteria, we did not detect statistically significant differences in feature visibility between modalities; CPMP additionally showed advantages in depth of field, field of view, and color rendering, whereas PD provided slightly crisper delineation of fine vascular structures. The modest inter- and intra-rater agreement suggests that the two modalities convey similar clinical interpretability, with individual preferences reflecting subtle perceptual differences rather than major technical disparities. Notably, evaluators showed consistent phenotype-dependent patterns, favoring CPMP in lesions rich in pigmented structures and PD in lesions dominated by fine vessels, indicating complementary strengths.

Cross-polarization has been widely adopted in visually driven specialties such as dermatology, dentistry, forensics, and ophthalmology to suppress surface glare and reveal subsurface structures.19 In dermatology, it has clinical value across diverse conditions, including inflammatory, pigmentary and vascular disorders.20–28 However, its use as a standalone, lesion-level approach for solitary tumors has remained limited, likely because cross-polarization was rapidly incorporated into dermoscopy devices, consolidating dermoscopy as the dominant modality for lesion-based assessment.29 Practical constraints also play a role: placing polarizing filters in front of flash illumination attenuates light output and forces compromises (eg, higher ISO, wider apertures, shorter working distances) that can increase noise, reduce depth of field, and challenge autofocus30 Dermoscopes partly overcome these issues through high-intensity LEDs placed close to the skin, but non-contact operation is typically limited to a few centimeters, as their short focal length restricts the focusing range and illumination falls rapidly with increasing distance.31 Novel ‘remote non-contact dermoscopy’ systems have been developed to capture dermoscope-equivalent images from a greater distance using ultra-bright LED illumination and distance-assisted autofocus; however, their shallow depth of field often necessitates computational post-processing, which adds workflow complexity.32–35

Our CPMP configuration occupies an intermediate position between handheld dermoscopy and remote platforms. Operating at ~10 cm, it combines a cross-polarizing filter with a powerful xenon ring flash and a macro lens, enabling small apertures (f/20) at base ISO to achieve deep focus and all-in-focus images in a single frame, without software-based post-processing. CPMP also captured the entire lesion and surrounding anatomical context in one high-resolution image, whereas PD may require overlapping images for larger tumors. Despite these advantages, lesion size and morphology did not significantly influence expert preference in this dataset. The absence of a significant effect of lesion size or morphology on preference may suggest that evaluators prioritized diagnostically relevant feature visibility over overall image quality. Thus, even when CPMP offered superior depth of field, preference may have depended more on the conspicuity of specific vascular or pigmented structures. The modest inter- and intra-rater consistency, despite this technical advantage, further suggests that evaluator preference was driven less by depth of field itself and more by subtle lesion-specific visual cues. Larger studies with broader panels are warranted to clarify whether these parameters affect clinician choice.

Differences in perceived color and sharpness may relate to illumination spectrum and device processing. Xenon ring-flash illumination provides a broad, near-continuous spectrum with high color-rendering performance, which may enhance chromophore separation and preserve red–brown hues. In contrast, smartphone-based PD using DermLite DL4/5 relies on phosphor-converted white LEDs with reduced red output, and automatic smartphone processing may preserve edge contrast at the expense of color saturation, rendering vascular details crisper but pigmentation less saturated.36 These factors offer a plausible explanation for the stronger performance of CPMP in pigmented lesions and PD in lesions with fine vascular structures.

Beyond their technical relevance, our findings may also have practical implications. In particular, CPMP may be useful for preoperative documentation by capturing the entire lesion and its surrounding anatomical context in a single high-resolution image. Its non-contact configuration may also be advantageous for lesions in anatomically sensitive areas or in situations where direct contact is undesirable. In addition, because CPMP uses widely available photographic equipment and produces context-rich images, it may have potential value in teledermatology and longitudinal visual documentation, although these applications require dedicated prospective study.

This study has several limitations. First, CPMP images were acquired with a DSLR sensor whereas PD images used a smartphone sensor; although reflective of real-world practice, this hardware difference complicates purely optical comparisons. Future studies using a shared sensor platform would better isolate the effect of illumination modality. Second, we focused exclusively on BCC; CPMP should be evaluated in other keratinocyte carcinomas and melanocytic lesions. Third, we assessed feature visibility and image quality rather than conducting a formal diagnostic accuracy study. In addition, no formal sample size calculation was performed; although the paired sample was likely sufficient to detect moderate-to-large differences between modalities, smaller differences may have gone undetected. No formal adjustment for multiple statistical testing was applied, so the findings should be interpreted with appropriate caution, particularly for smaller or subgroup-specific differences. Furthermore, because one CPMP and one PD image judged to best represent each lesion were selected from consecutively acquired images, some degree of selection bias toward more favorable images may have been introduced. Finally, the DIQS-5 image-quality scale was developed specifically for this study and has not yet been externally validated.

Conclusions

In conclusion, CPMP provides lesion-level information broadly comparable to non-contact PD for BCC, while offering practical advantages in field of view, depth of field and color rendering. The phenotype-dependent preference patterns suggest that CPMP and PD have complementary strengths, with CPMP offering particular advantages for larger, more pigmented, or anatomically challenging lesions, as well as in settings where non-contact imaging or preoperative documentation is desirable. Given the exploratory nature of the subgroup findings and the modest inter-rater reliability observed, CPMP should be regarded as a complement to dermoscopy rather than a substitute for it. Future studies should evaluate the diagnostic accuracy of CPMP, externally validate the DIQS-5 scale, and assess its applicability in other skin cancer types.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Ethical Approval

The study was conducted in accordance with the Declaration of Helsinki. The study protocol was reviewed and approved by the Istanbul Medeniyet University Institutional Review Board (approval no. 2025/06-21).

Consent for Publication

Written informed consent was obtained from all participants for the use and publication of their images.

Acknowledgment

Open access publication of this article was supported by the Turkish Dermatology Association. Abdurrahim Yilmaz has been funded by the President’s PhD Scholarships at Imperial College London, which solely supported his academic studies.

Funding

This article has no funding source.

Disclosure

The authors report no conflicts of interest in this work.

References

1. C VJ, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177(2):359–12. doi:10.1111/bjd.15321

2. Wu X, Elkin EE, Marghoob AA. Burden of basal cell carcinoma in USA. Future Oncol. 2015. doi:10.2217/fon.15.180

3. Khalil AA, Enezei HH, Aldelaimi TN, Mohammed KA. Advances in diagnosis and treatment of basal cell carcinoma. J Craniofac Surg. 2024;35(2):e204–e208. doi:10.1097/SCS.0000000000009959

4. Peris K, Fargnoli MC, Kaufmann R, et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023. Eur J Cancer. 2023;192:113254. doi:10.1016/j.ejca.2023.113254

5. Bakos RM, Blumetti TP, Roldán-Marín R, Salerni G. Noninvasive imaging tools in the diagnosis and treatment of skin cancers. Am J Clin Dermatol. 2018;19(S1):3–14. doi:10.1007/s40257-018-0367-4

6. Janowska A, Oranges T, Granieri G, et al. Non-invasive imaging techniques in presurgical margin assessment of basal cell carcinoma: current evidence. Skin Res Technol. 2023;29(2):e13271. doi:10.1111/srt.13271

7. Negrutiu M, Danescu S, Popa T, et al. Advancements in basal cell carcinoma diagnosis: non-invasive imaging and multimodal approach. J Clin Med. 2023;13(1). doi:10.3390/jcm13010039

8. Boostani M, Pellacani G, Wortsman X, et al. FDA and EMA-approved noninvasive imaging techniques for basal cell carcinoma subtyping: a systematic review. JAAD Int. 2025;21:73–86. doi:10.1016/j.jdin.2025.05.006

9. Anderson RR. Polarized light examination and photography of the skin. Arch Dermatol. 1991;127(7):1000–1005.

10. McFall K. Photography of dermatological conditions using polarized light. J Audiov Media Med. 1996;19(1):5–9. doi:10.3109/17453059609018381

11. Benvenuto-Andrade C, Dusza SW, Agero ALC, et al. Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions. Arch Dermatol. 2007;143(3):329–338. doi:10.1001/archderm.143.3.329

12. Pan Y, Gareau DS, Scope A, et al. Polarized and nonpolarized dermoscopy: the explanation for the observed differences. Arch Dermatol. 2008;144(6):828–829. doi:10.1001/archderm.144.6.828

13. Marchetti MA, Nazir ZH, Nanda JK, et al. 3D Whole-body skin imaging for automated melanoma detection. J Eur Acad Dermatol Venereol. 2023;37(5):945–950. doi:10.1111/jdv.18924

14. Winkler JK, Kommoss KS, Toberer F, et al. Performance of an automated total body mapping algorithm to detect melanocytic lesions of clinical relevance. Eur J Cancer. 2024;202:114026. doi:10.1016/j.ejca.2024.114026

15. Malvehy J, Dermoscopy PG. Confocal microscopy and other non-invasive tools for the diagnosis of non-melanoma skin cancers and other skin conditions. Acta Derm Venereol. 2017;Suppl 218:22–30. doi:10.2340/00015555-2720

16. Göktay F, Erdem O. Cross-polarized photography of the nail unit: a practical way to eliminate specular reflections on the nail plate. Skin Appendage Disord. 2023;9(4):313–316. doi:10.1159/000530670

17. Erdem O, Göktay F, Atış G, Erdemir VA. How we do it: intraoperative cross-polarized photography as an alternative to intraoperative dermoscopy during nail surgery. Dermatol Surg off Publ Am Soc Dermatol Surg Al. 2024;50(2):213–214. doi:10.1097/DSS.0000000000004025

18. Wozniak-Rito A, Zalaudek I, Rudnicka L. Dermoscopy of basal cell carcinoma. Clin Exp Dermatol. 2018;43(3):241–247. doi:10.1111/ced.13387

19. Hanlon KL. Cross-polarised and parallel-polarised light: viewing and photography for examination and documentation of biological materials in medicine and forensics. J Vis Commun Med. 2018;41(1):3–8. doi:10.1080/17453054.2018.1420418

20. Muccini JA, Kollias N, Phillips SB, et al. Polarized light photography in the evaluation of photoaging. J Am Acad Dermatol. 1995;33(5 Pt 1):765–769. doi:10.1016/0190-9622(95)91813-2

21. Rizova E, Kligman A. New photographic techniques for clinical evaluation of acne. J Eur Acad Dermatol Venereol JEADV. 2001;15 Suppl 3:13–18. doi:10.1046/j.1468-3083.15.s.3.1.x

22. Jung B, Choi B, Durkin AJ, Kelly KM, Nelson JS. Characterization of port wine stain skin erythema and melanin content using cross-polarized diffuse reflectance imaging. Lasers Surg Med. 2004;34(2):174–181. doi:10.1002/lsm.10242

23. Farage MA. Enhancement of visual scoring of skin irritant reactions using cross-polarized light and parallel-polarized light. Contact Dermatitis. 2008;58(3):147–155. doi:10.1111/j.1600-0536.2007.01284.x

24. Ortonne JP, Gupta G, Ortonne N, et al. Effectiveness of cross polarized light and fluorescence diagnosis for detection of sub-clinical and clinical actinic keratosis during imiquimod treatment. Exp Dermatol. 2010;19(7):641–647. doi:10.1111/j.1600-0625.2009.01047.x

25. Foolad N, Prakash N, Shi VY, et al. The use of facial modeling and analysis to objectively quantify facial redness. J Cosmet Dermatol. 2016;15(1):43–48. doi:10.1111/jocd.12191

26. Kohli I, Kastner S, Thomas M, et al. Quantitative measurement of skin surface oiliness and shine using differential polarized images. Arch Dermatol Res. 2021;313(2):71–77. doi:10.1007/s00403-020-02070-5

27. Oh Y, Markova A, Noor SJ, Rotemberg V. Standardized clinical photography considerations in patients across skin tones. Br J Dermatol. 2022;186(2):352–354. doi:10.1111/bjd.20766

28. Hanlon KL, Cohen G, Grichnik JM, Gonzalez-Estrada A. Cross-polarized lighting technique as a tool to visualize a hive in skin of color. J Allergy Clin Immunol Pract. 2023;11(10):3235–3237. doi:10.1016/j.jaip.2023.07.005

29. Wang SQ, Marghoob AA, Scope A. Principles of dermoscopy and dermoscopic equipment. In: An Atlas of Dermoscopy. 2nd ed. CRC Press; 2012.

30. Edwards N. Cross-polarisation, making it practical. J Vis Commun Med. 2011;34(4):165–172. doi:10.3109/17453054.2011.635291

31. Lake A, Jones B. Dermoscopy: to cross-polarize, or not to cross-polarize, that is the question: a literature review. J Vis Commun Med. 2015;38(1–2):36–50. doi:10.3109/17453054.2015.1046371

32. Jütte L, Yang Z, Sharma G, Roth B. Focus stacking in non-contact dermoscopy. Biomed Phys Eng Express. 2022;8(6):065022.

33. Meinhardt-Wollweber M, Heratizadeh A, Basu C, et al. A non-contact remote digital dermoscope to support cancer screening and diagnosis of inflammatory skin disease. Biomed Phys Eng Express. 2017;3(5):055005. doi:10.1088/2057-1976/aa84d3

34. Fricke D, Denker E, Heratizadeh A, et al. Non-contact dermatoscope with ultra-bright light source and liquid lens-based autofocus function. Appl Sci. 2019;9(11). doi:10.3390/app9112177

35. Heratizadeh A, Fricke D, Meinhardt-Wollweber M, Roth B, Werfel T. Non-contact remote digital dermoscopy - new perspectives on differential diagnosis of inflammatory skin diseases. J Eur Acad Dermatol Venereol JEADV. 2020;34(3):e125–e126. doi:10.1111/jdv.16056

36. Hanlon KL, Wei G, Correa-Selm L, Grichnik JM. Dermoscopy and skin imaging light sources: a comparison and review of spectral power distribution and color consistency. J Biomed Opt. 2022;27(08). doi:10.1117/1.JBO.27.8.080902

Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.